| Primary |
| Atrial Fibrillation |
45.2% |
| Product Used For Unknown Indication |
14.7% |
| Arrhythmia |
4.4% |
| Drug Use For Unknown Indication |
4.4% |
| Hypertension |
3.9% |
| Supraventricular Tachycardia |
3.6% |
| Tachycardia |
3.3% |
| Atrial Flutter |
3.0% |
| Arrhythmia Prophylaxis |
2.2% |
| Anaesthesia |
1.9% |
| Intentional Overdose |
1.9% |
| Atrial Tachycardia |
1.4% |
| Drug Toxicity |
1.4% |
| Peritoneal Tuberculosis |
1.4% |
| Suicide Attempt |
1.4% |
| Tachycardia Foetal |
1.4% |
| Electrocardiogram Qt Prolonged |
1.1% |
| Heart Rate Irregular |
1.1% |
| Neuralgia |
1.1% |
| Nodal Arrhythmia |
1.1% |
|
| Tachycardia |
13.7% |
| Ventricular Tachycardia |
9.6% |
| Syncope |
8.2% |
| Toxicity To Various Agents |
7.5% |
| Brugada Syndrome |
5.5% |
| Completed Suicide |
4.8% |
| Sudden Cardiac Death |
4.8% |
| Electrocardiogram Abnormal |
4.1% |
| Hyponatraemia |
4.1% |
| Overdose |
4.1% |
| Torsade De Pointes |
4.1% |
| Vomiting |
4.1% |
| Drug Interaction |
3.4% |
| Intentional Overdose |
3.4% |
| Product Taste Abnormal |
3.4% |
| Suicide Attempt |
3.4% |
| Vision Blurred |
3.4% |
| Atrial Flutter |
2.7% |
| Cough |
2.7% |
| Drug Eruption |
2.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.3% |
| Atrial Fibrillation |
18.7% |
| Hypertension |
12.0% |
| Ill-defined Disorder |
8.2% |
| Product Used For Unknown Indication |
8.0% |
| Arrhythmia |
4.8% |
| Atrial Flutter |
3.5% |
| Intentional Overdose |
2.3% |
| Type 2 Diabetes Mellitus |
1.4% |
| Cardiac Disorder |
1.2% |
| Hyperlipidaemia |
1.1% |
| Heart Rate Irregular |
1.0% |
| Hypothyroidism |
1.0% |
| Prophylaxis |
1.0% |
| Blood Pressure Increased |
0.9% |
| Depression |
0.9% |
| Pyrexia |
0.9% |
| Renal Transplant |
0.9% |
| Respiratory Disorder |
0.9% |
| Ventricular Tachycardia |
0.9% |
|
| Vomiting |
14.9% |
| Drug Interaction |
8.0% |
| Pyrexia |
8.0% |
| Syncope |
8.0% |
| Vision Blurred |
7.5% |
| Palpitations |
6.9% |
| Ventricular Tachycardia |
6.9% |
| Atrial Fibrillation |
3.4% |
| Overdose |
3.4% |
| Therapeutic Response Decreased |
3.4% |
| Transaminases Increased |
3.4% |
| Ventricular Arrhythmia |
3.4% |
| Vertigo |
3.4% |
| Atrial Flutter |
2.9% |
| Cardio-respiratory Arrest |
2.9% |
| Malaise |
2.9% |
| Muscular Weakness |
2.9% |
| Rales |
2.9% |
| Completed Suicide |
2.3% |
| Drug Ineffective |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.9% |
| Atrial Fibrillation |
15.9% |
| Drug Use For Unknown Indication |
12.3% |
| Hypertension |
11.1% |
| Rheumatoid Arthritis |
7.3% |
| Arrhythmia |
5.7% |
| Prophylaxis |
4.4% |
| Osteoporosis |
2.7% |
| Blood Cholesterol Increased |
2.5% |
| Depression |
2.1% |
| Pain |
2.0% |
| Cardiac Disorder |
1.9% |
| Hypothyroidism |
1.8% |
| Multiple Myeloma |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Asthma |
1.6% |
| Diabetes Mellitus |
1.5% |
| Anxiety |
1.3% |
| Supplementation Therapy |
1.2% |
|
| Vomiting |
8.2% |
| Vision Blurred |
6.6% |
| International Normalised Ratio Increased |
6.3% |
| Atrial Fibrillation |
6.1% |
| Pain In Extremity |
6.1% |
| Weight Decreased |
5.8% |
| Renal Failure Acute |
5.5% |
| Transient Ischaemic Attack |
5.5% |
| Drug Ineffective |
5.3% |
| Pruritus |
5.3% |
| Tremor |
5.0% |
| Dizziness |
4.2% |
| Syncope |
4.2% |
| Fatigue |
3.9% |
| Loss Of Consciousness |
3.9% |
| Nausea |
3.9% |
| Pyrexia |
3.7% |
| Thrombocytopenia |
3.7% |
| Oedema Peripheral |
3.4% |
| Pneumonia |
3.4% |
|
| Interacting |
| Atrial Fibrillation |
19.0% |
| Hepatitis C |
17.9% |
| Hypertension |
14.3% |
| Cardiomyopathy |
6.0% |
| Tachycardia |
6.0% |
| Anaesthesia |
4.8% |
| Arrhythmia |
4.8% |
| Asthma |
4.8% |
| Pneumonia |
4.8% |
| Drug Use For Unknown Indication |
3.6% |
| Product Used For Unknown Indication |
3.6% |
| Bronchitis |
2.4% |
| Diuretic Therapy |
1.2% |
| Dyspepsia |
1.2% |
| Fungal Infection |
1.2% |
| Glaucoma |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Renal Failure Chronic |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
|
| Drug Interaction |
19.2% |
| Hypotension |
11.5% |
| Atrial Fibrillation |
7.7% |
| Loss Of Consciousness |
7.7% |
| Myoclonus |
7.7% |
| Rash |
7.7% |
| Vision Blurred |
7.7% |
| Fatigue |
3.8% |
| Haematocrit Decreased |
3.8% |
| Incorrect Dose Administered |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Palpitations |
3.8% |
| Potentiating Drug Interaction |
3.8% |
| Syncope |
3.8% |
| Varicose Ulceration |
3.8% |
|
